BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 11194933)

  • 1. Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes.
    Aso Y; Inukai T; Tayama K; Takemura Y
    Acta Diabetol; 2000; 37(2):87-92. PubMed ID: 11194933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.
    Miura J; Yamagishi Si; Uchigata Y; Takeuchi M; Yamamoto H; Makita Z; Iwamoto Y
    J Diabetes Complications; 2003; 17(1):16-21. PubMed ID: 12505751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
    Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
    Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes.
    Berg TJ; Snorgaard O; Faber J; Torjesen PA; Hildebrandt P; Mehlsen J; Hanssen KF
    Diabetes Care; 1999 Jul; 22(7):1186-90. PubMed ID: 10388987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end products in adolescents and young adults with diabetic angiopathy.
    Chiarelli F; Catino M; Tumini S; Cipollone F; Mezzetti A; Vanelli M; Verrotti A
    Pediatr Nephrol; 2000 Aug; 14(8-9):841-6. PubMed ID: 10955941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum levels of advanced glycation end-products and diabetic complications.
    Ono Y; Aoki S; Ohnishi K; Yasuda T; Kawano K; Tsukada Y
    Diabetes Res Clin Pract; 1998 Aug; 41(2):131-7. PubMed ID: 9789719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes.
    Hirata K; Kubo K
    Endocr J; 2004 Dec; 51(6):537-44. PubMed ID: 15644571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of advanced glycation endproducts in patients with type 2 diabetes and various stages of proteinuria.
    Turk N; Mornar A; Mrzljak V; Turk Z
    Diabetes Metab; 2004 Apr; 30(2):187-92. PubMed ID: 15223992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel advanced glycation index and its association with diabetes and microangiopathy.
    Sampathkumar R; Balasubramanyam M; Rema M; Premanand C; Mohan V
    Metabolism; 2005 Aug; 54(8):1002-7. PubMed ID: 16092048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma NT-proBNP is independently associated with albuminuria in type 2 diabetes.
    Zhou L; Cai X; Li M; Han X; Ji L
    J Diabetes Complications; 2016; 30(4):669-74. PubMed ID: 26922580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stiffening of connective tissue in elderly diabetic patients: relevance to diabetic nephropathy and oxidative stress.
    Aoki Y; Yazaki K; Shirotori K; Yanagisawa Y; Oguchi H; Kiyosawa K; Furuta S
    Diabetologia; 1993 Jan; 36(1):79-83. PubMed ID: 8436258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.
    Ak G; Buyukberber S; Sevinc A; Turk HM; Ates M; Sari R; Savli H; Cigli A
    J Diabetes Complications; 2001; 15(3):150-7. PubMed ID: 11358684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy.
    Parving HH; Nielsen FS; Bang LE; Smidt UM; Svendsen TL; Chen JW; Gall MA; Rossing P
    Diabetologia; 1996 Dec; 39(12):1590-7. PubMed ID: 8960847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of measurements of urinary and serum thrombomodulins in patients with non-insulin-dependent diabetes mellitus.
    Inukai T; Fujiwara Y; Tayama K; Aso Y; Takemura Y
    Diabetes Res Clin Pract; 1996 Jul; 33(2):99-104. PubMed ID: 8879964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycated peptides are associated with the variability of endothelial dysfunction in the cerebral vessels and the kidney in type 2 diabetes mellitus patients: a cross-sectional study.
    Petrica L; Vlad A; Gluhovschi G; Gadalean F; Dumitrascu V; Vlad D; Popescu R; Velciov S; Gluhovschi C; Bob F; Ursoniu S; Petrica M; Jianu DC
    J Diabetes Complications; 2015 Mar; 29(2):230-7. PubMed ID: 25511877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Levels of Antibodies to Advanced Glycation End Products in Patients with Type 2 Diabetes Mellitus and Hypertension.
    Nikolov A; Blazhev A; Tzekova M; Kostov K; Popovski N
    Folia Med (Plovdiv); 2020 Jun; 62(2):295-301. PubMed ID: 32666760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased basal levels of plasma nitric oxide in Type 2 diabetic subjects. Relationship to microvascular complications.
    Maejima K; Nakano S; Himeno M; Tsuda S; Makiishi H; Ito T; Nakagawa A; Kigoshi T; Ishibashi T; Nishio M; Uchida K
    J Diabetes Complications; 2001; 15(3):135-43. PubMed ID: 11358682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy.
    Asakawa H; Tokunaga K; Kawakami F
    J Diabetes Complications; 2000; 14(3):121-6. PubMed ID: 10989319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus.
    Fosmark DS; Torjesen PA; Kilhovd BK; Berg TJ; Sandvik L; Hanssen KF; Agardh CD; Agardh E
    Metabolism; 2006 Feb; 55(2):232-6. PubMed ID: 16423631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of the progression of complications in patients with type 2 diabetes: a one-year longitudinal study.
    Preciado-Puga MC; Malacara JM; Fajardo-Araujo ME; Wröbel K; Wröbel K; Kornhauser-Araujo C; Garay-Sevilla ME
    Exp Clin Endocrinol Diabetes; 2014 Sep; 122(8):484-90. PubMed ID: 25230243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.